Brief: MoonLake Immunotherapeutics Reports Second Quarter 2025 Financial Results And Provides A Business Update
05/08/2025 14:27
Aug 5 (Reuters) - MoonLake Immunotherapeutics MLTX.O: MOONLAKE IMMUNOTHERAPEUTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE MOONLAKE IMMUNOTHERAPEUTICS - PHASE 3 VELA PROGRAM IN HS ON TRACK FOR SEPT 2025 PRIMARY ENDPOINT READOUT Source text: ID:nGNX1jJxbT Further company coverage: MLTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MoonLake Immunotherapeutics
See all newsMoonLake jumps as AbbVie's weak skin drug data eases competition fears
Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed
MoonLake Immunotherapeutics reports results for the quarter ended June 30 - Earnings Summary
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial (updated)
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial